Physician profile
Daniel J Leeman
NPI 1508849696
$9,974.12
in general payments reported to CMS, 2019-2025
26 companies · $1,297 in 2025
The $1,297 reported for 2025 was more than what 85% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,926 · 2020: $847 · 2021: $2,022 · 2022: $1,861 · 2023: $1,036 · 2024: $986 · 2025: $1,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,994 · Long Term Medical Supply Or Device Loan: $226 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,994.10 |
| Long Term Medical Supply Or Device Loan | $226.19 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,153.91 | 2019-2025 | Audion Et Dilation System, Xpress Ent Dilation System, Scopis Ent |
| Genzyme Corporation | $1,474.01 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,100.88 | 2020-2025 | Dupixent |
| Galderma Laboratories, L.P. | $571.09 | 2019-2020 | |
| Medtronic, INC. | $458.69 | 2021-2025 | Propel, Stealthstation S8 Platform |
| Solta Medical, A Division of Bausch Health US, LLC | $414.50 | 2019-2023 | |
| Integra Lifesciences Corporation | $383.96 | 2021-2025 | Amnioexcel Plus, Integra, Trudi Probe |
| Olympus America INC. | $282.32 | 2019-2022 | |
| Hill Dermaceuticals, INC. | $224.05 | 2022 | |
| Glaxosmithkline, LLC. | $194.66 | 2021-2025 | Nucala |
| Wound Management Technologies, INC | $186.20 | 2019 | |
| Acclarent, INC | $153.28 | 2019-2023 | Relieva Ultirra |
| Alk-Abello, INC | $45.54 | 2023 | Ragwitek, Grastek, Odactra |
| Acelrx Pharmaceuticals, INC. | $45.34 | 2021 | |
| Aerin Medical INC. | $38.20 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $37.61 | 2019 | |
| Itamar Medical INC | $35.42 | 2022-2023 | Watchpatone |
| Mimedx Group, INC. | $30.39 | 2025 | |
| Optinose US, INC. | $29.21 | 2021 | |
| Sanara Medtech INC. | $23.91 | 2025 | Celleraterx |
| Carestream Dental, LLC | $17.85 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.68 | 2019 | |
| Allergan, INC. | $15.82 | 2022 | |
| Hikma Pharmaceuticals USA | $15.26 | 2024 | Ryaltris |
| Osteomed LLC | $13.99 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Leeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.